174 related articles for article (PubMed ID: 9359845)
1. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.
van Berkel PH; Geerts ME; van Veen HA; Mericskay M; de Boer HA; Nuijens JH
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):145-51. PubMed ID: 9359845
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies against human lactoferrin.
van Berkel PH; van Veen HA; Geerts ME; Nuijens JH
J Immunol Methods; 2002 Sep; 267(2):139-50. PubMed ID: 12165435
[TBL] [Abstract][Full Text] [Related]
4. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis.
van Berkel PH; Geerts ME; van Veen HA; Kooiman PM; Pieper FR; de Boer HA; Nuijens JH
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):107-14. PubMed ID: 7492299
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
[TBL] [Abstract][Full Text] [Related]
6. Characterization of recombinant human lactoferrin secreted in milk of transgenic mice.
Nuijens JH; van Berkel PH; Geerts ME; Hartevelt PP; de Boer HA; van Veen HA; Pieper FR
J Biol Chem; 1997 Mar; 272(13):8802-7. PubMed ID: 9079716
[TBL] [Abstract][Full Text] [Related]
7. Analytical cation-exchange chromatography to assess the identity, purity, and N-terminal integrity of human lactoferrin.
van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
Anal Biochem; 2002 Oct; 309(1):60-6. PubMed ID: 12381362
[TBL] [Abstract][Full Text] [Related]
8. High-level expression of bioactive recombinant human lysozyme in the milk of transgenic mice using a modified human lactoferrin BAC.
Liu S; Li X; Lu D; Shang S; Wang M; Zheng M; Zhang R; Tang B; Li Q; Dai Y; Li N
Transgenic Res; 2012 Apr; 21(2):407-14. PubMed ID: 21805108
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.
Elass-Rochard E; Legrand D; Salmon V; Roseanu A; Trif M; Tobias PS; Mazurier J; Spik G
Infect Immun; 1998 Feb; 66(2):486-91. PubMed ID: 9453600
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.
Caccavo D; Afeltra A; Pece S; Giuliani G; Freudenberg M; Galanos C; Jirillo E
Infect Immun; 1999 Sep; 67(9):4668-72. PubMed ID: 10456914
[TBL] [Abstract][Full Text] [Related]
11. Role of the first N-terminal basic cluster of human lactoferrin (R2R3R4R5) in the interactions with the Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Adv Exp Med Biol; 1998; 443():49-55. PubMed ID: 9781342
[TBL] [Abstract][Full Text] [Related]
12. Generation of bi-transgenic pigs overexpressing human lactoferrin and lysozyme in milk.
Cui D; Li J; Zhang L; Liu S; Wen X; Li Q; Zhao Y; Hu X; Zhang R; Li N
Transgenic Res; 2015 Apr; 24(2):365-73. PubMed ID: 25236863
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding properties of lactoferrin and lysozyme.
Zou S; Magura CE; Hurley WL
Comp Biochem Physiol B; 1992 Dec; 103(4):889-95. PubMed ID: 1478067
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: the role of cell surface sulphated molecules.
Roşeanu A; Chelu F; Trif M; Motaş C; Brock JH
Biochim Biophys Acta; 2000 Jun; 1475(1):35-8. PubMed ID: 10806335
[TBL] [Abstract][Full Text] [Related]
15. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis.
van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
Eur J Biochem; 2004 Feb; 271(4):678-84. PubMed ID: 14764083
[TBL] [Abstract][Full Text] [Related]
16. Non-reducing terminal fucose within N-linked glycan plays a significant role in the recognition of human milk lactoferrin by the 1CF11 monoclonal antibody.
Fukaya S; Yabe T; Kanamaru Y
Biosci Biotechnol Biochem; 2010; 74(10):2141-4. PubMed ID: 20944405
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.
van Berkel PH; van Veen HA; Geerts ME; de Boer HA; Nuijens JH
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):117-22. PubMed ID: 8870657
[TBL] [Abstract][Full Text] [Related]
18. Role of basic residues of human lactoferrin in the interaction with B lymphocytes.
Kawasaki Y; Sato K; Shinmoto H; Dosako S
Biosci Biotechnol Biochem; 2000 Feb; 64(2):314-8. PubMed ID: 10737187
[TBL] [Abstract][Full Text] [Related]
19. Production of human lactoferrin in animal milk.
Goldman IL; Georgieva SG; Gurskiy YG; Krasnov AN; Deykin AV; Popov AN; Ermolkevich TG; Budzevich AI; Chernousov AD; Sadchikova ER
Biochem Cell Biol; 2012 Jun; 90(3):513-9. PubMed ID: 22360490
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the chondroitin sulfate-binding characteristics of human lactoferrin to neutralize neurite outgrowth inhibition.
Nakamura M; Matsuzaki T; Iimori A; Sato A
Biochem Biophys Res Commun; 2021 Jan; 534():1076-1082. PubMed ID: 33129446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
